Loncastuximab Tesirine

ATC L01FX22 · 9 markets · 10 records

Loncastuximab Tesirine 9 markets · 10 records Forms

AU 2 records · 2 strengths

  • 10 mginjectionZYNLONTA loncastuximab tesirine 10 mg powder for concentrate for solution for infusion vial also in GB·TW unknown

Records without a stated strength · 1 ZYNLONTA

US 1 records · 1 strengths

GB 1 records · 1 strengths

  • 10 mginjectionZynlonta 10mg powder for concentrate for solution for infusion vials also in AU·TW

CA 1 records · 1 strengths

SG 1 records · 1 strengths

  • 10 mg/vialinjectionZYNLONTA® FOR INJECTION 10MG/VIAL

TW 1 records · 1 strengths

HK 1 records · 1 strengths

    Records without a stated strength · 1 Zynlonta 10 mg powder for concentrate for solution for infusion

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 ZYNLONTA

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.